A study to find correlation of platelet indices with HbA1c in diabetic patients with absence/presence of vascular complications

Ishan Dubey, Bindu Singh Gaur, Roma Singh


Background: Diabetes Mellitus is a global pandemic disease. The increased platelet activity is emphasized to play a role in the development of vascular complications of the metabolic disorder. Mean platelet volume (MPV) is an indicator of average size and activity of platelets. This study was conducted to find correlation of platelet indices with HbA1c in diabetic patients with absence/presence of vascular complications.

Methods: Total of 100 subjects was enrolled in the study. Sample for glucose estimation and platelet indices were collected and estimation were carried out by the auto-analyzers. The statistical evaluation is done using SPSS version 22. Student t- test was used for doing comparison between two variables namely HbA1c <7 and HbA1c ≥7 and diabetics with vascular complications v/s without vascular complications.

Results: MPV, is significantly higher in patients with type -2 diabetes mellitus with HbA1C ≥7 and those with vascular complications in comparison to patients having HbA1c <7 and those without vascular complications ( p- value <0.001 which is highly significant).

Conclusions: MPV might be used as a simple and cost-effective laboratory test in the follow up of diabetes mellitus along with HbA1c and thereby help to reduce the morbidity and mortality.


Diabetic mellitus, Mean platelet volume, Vascular complications

Full Text:



Kodiatte TA, Manikyam UK, Rao SB, Jagadish TM, Reddy M, Lingaiah HM, Lashmaiah V. Mean platelet volume in type 2 diabetes mellitus. J Lab Pysician. 2012;4:5-9.

Demirtune R, Duman D, Basar M, Bilgi M, Teomete M, Garip T. The relationship between gylcemic control and platelet activity in type 2 diabetes mellitus. J Diabetes complications. 2009;23:89-94.

Update 2014. International Diabetic Federation [IDF]. Williams Textbook of Endocrinology.12th edition. Philadelphia: Elsevier/Saunders. 2014:1371-435.

Zimmet P, Alberti KG, Shaw J. Global and social implication of the diabetes epidemics. Nature 2001;414:782-7.

Shi Y, Hu FB. The global implication of diabetes and cancer. Lancet. 2014 Jun 7;383(9933):1947-8.

Groop L, OrhoMelander M. The dysmetabolic syndrome .J Intern Med. 2001;250:105-20.

Haffner SM, Lehto S, Ronnemaa T, Pyörälä K, Laakso M. Mortality from coronary artery disease in subjects with type 2 diabetes and in non- diabetic subjects with and without prior myocardial infarction. N Engl Med. 1998:229-34.

Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pederson O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-93.

Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR et al. Mortality from heart disease in cohort of 23,000 patients with insulin treated diabetes. Diabetologia. 2003;46:760-5.

Colwell JA, Nesto RW. The platelet in diabetes. Focus on prevention of ischemic events. Diabetes care 2003;2:2181-8.

Yazbek N, Bapat A, Kleiman N. Platelet abnormalities in diabetes mellitus. Coron Artery Dis 2003;114:365-71.

Porta M, Peters AM, Cousins SA, Cagliero E, FitzPatrick ML, Kohner EM. A study of platelet-relevant parameter in patient with diabetic microangiopathy. Diabetologia. 1983;25:21-5.

Yngen M, Ostnson CG, Li N, Hjemdahl P, Wallen NH. Acute hyperglycemia increases soluble P- selectin in male patients with mild diabetes mellitus. Blood Coagul Fibrinolysis. 2001;12:109-16

Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2004 Dec;15(8):475-8.

Sharpe PC, Trinick T. Mean platelet volume in diabetes mellitus. QJ Med. 1993;86:739-42.

Wiwanitkit V. Platelet crit, mean platelet volume, platelet distribution width: its expected values and correlation with parallel red blood cell parameters. Clin Appl Thromb Hemost. 2004;10(2):175-8.

Tschoepe D, Roesen P, Kaufmann L, Schauseil S, Kehrel B, Ostermann H et al. Evidence of abnormal platelet expression in diabetes mellitus. Eur J Clin Invest.1990;20(2):166-70.

Ebil N, Krugluger W, Strait G, Hopemier P, Scherntham G. Improved metabolic control decreases platelet activation marker in patient with type 2 diabetes mellitus. Eur J clin Invest. 2004;34(3):205-9.

Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B et al. Mean platelet volume asa predictor of cardiovascular risk: a systematic review and meta- analysis. J Thromb Haemost. 2010;8:148-56.

O'Malley T, Langhorne P, Elton RA, Stewart C. Platelet size in stroke patient. Stroke. 1995;26:995-9.

American Diabetes Association. Diabetes Care 2014 Jan; 37(Supplement 1): S14-80.

Li S, Wang C, Zhong XW, Li HQ, Fu XQ, Ran XW. Variance of Mean platelet volume in subjects with normal glucose tolerance ,impaired glucose regulation and type 2 diabetes mellitus and its relationship with diabetic PAD. Zhonghua Yi Xue Za Zhi. 2012;92(4):232-5.

Lutfullah Cakir, Gulali Aktas. Mean Platelet Volume increases in type 2 diabetes mellitus independent of HbA1C levels. Acta Medica Mediterranea. 2014,30:425.

Ozder A, Eker HH. Investigation of mean platelet volume in patient with type 2 diabetes and in subjects with Impaired fasting glucose; a cost-effective tool in primary health care. Int J Clin Exp Med. 2014;7(8):2292-7.

Gresele P, Guglielmini G. Acute, short-Term hyperglycaemia enhances shear stress-induced platelet activation in patients with type 2 diabetes mellitus. JACC. 2003;41(6):1013-20.

Jabeen F, Rizv HA. Hyperglycemic induced variations in Hematological Indices in Type 2 Diabetics. Int J Advanc Res. 2013;1:322-34.

Ulutas KT, Dokuyucu R, Sefil F, Yengil E, Sumbul AT, Rizaoglu H et al. Evalution of MPV in patients with type 2 diabetes mellitus and blood glucose regulation: A marker of atherosclerosis. Int J Clin Exp Med. 2014;7(4):955-61.